Joseph S. Warmus

2.3k total citations
38 papers, 962 citations indexed

About

Joseph S. Warmus is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph S. Warmus has authored 38 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 18 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph S. Warmus's work include Asymmetric Synthesis and Catalysis (8 papers), Chemical Synthesis and Analysis (7 papers) and Coordination Chemistry and Organometallics (4 papers). Joseph S. Warmus is often cited by papers focused on Asymmetric Synthesis and Catalysis (8 papers), Chemical Synthesis and Analysis (7 papers) and Coordination Chemistry and Organometallics (4 papers). Joseph S. Warmus collaborates with scholars based in United States, United Kingdom and China. Joseph S. Warmus's co-authors include William Roush, A. I. MEYERS, Bradley Brown, Robert M. Kennedy, Haile Tecle, Michael A. Gonzalez, Cathlin Flamme, Joseph W. Guiles, Stephen D. Barrett and Wilbur R. Leopold and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Joseph S. Warmus

37 papers receiving 925 citations

Peers

Joseph S. Warmus
Jakyung Yoo South Korea
Dafydd R. Owen United Kingdom
John J. Piwinski United States
Andrew J. Peat United States
Kevin N. Dack United Kingdom
Jefferson Tilley United States
Randall W. Hungate United States
Herman H. Stein United States
Jakyung Yoo South Korea
Joseph S. Warmus
Citations per year, relative to Joseph S. Warmus Joseph S. Warmus (= 1×) peers Jakyung Yoo

Countries citing papers authored by Joseph S. Warmus

Since Specialization
Citations

This map shows the geographic impact of Joseph S. Warmus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph S. Warmus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph S. Warmus more than expected).

Fields of papers citing papers by Joseph S. Warmus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph S. Warmus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph S. Warmus. The network helps show where Joseph S. Warmus may publish in the future.

Co-authorship network of co-authors of Joseph S. Warmus

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph S. Warmus. A scholar is included among the top collaborators of Joseph S. Warmus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph S. Warmus. Joseph S. Warmus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Brendan, Scott A. Hollingsworth, David C. Blakemore, et al.. (2021). Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor. Journal of Chemical Information and Modeling. 61(7). 3696–3707. 18 indexed citations
2.
Brown, Alan D., Sharan K. Bagal, David C. Blakemore, et al.. (2018). The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain. Bioorganic & Medicinal Chemistry. 27(1). 230–239. 22 indexed citations
3.
Bechle, Bruce M., et al.. (2018). Development of a scalable synthetic route towards a 2,2,6-trisubstituted chiral morpholine via stereoselective hydroalkoxylation. Tetrahedron Letters. 59(19). 1808–1812. 5 indexed citations
4.
Pryde, David C., Nigel A. Swain, Paul A. Stupple, et al.. (2017). The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics. MedChemComm. 8(6). 1255–1267. 6 indexed citations
5.
Pryde, David C., Brian E. Marron, Christopher W. West, et al.. (2017). Discovery of a Series of Indazole TRPA1 Antagonists. ACS Medicinal Chemistry Letters. 8(6). 666–671. 19 indexed citations
6.
Albrow, Victoria E., Rachel L. Grimley, Colin R. Rose, et al.. (2016). Design and development of histone deacetylase (HDAC) chemical probes for cell-based profiling. Molecular BioSystems. 12(6). 1781–1789. 10 indexed citations
7.
McAlpine, Indrawan, Michelle Tran‐Dubé, Fen Wang, et al.. (2015). Synthesis of Small 3-Fluoro- and 3,3-Difluoropyrrolidines Using Azomethine Ylide Chemistry. The Journal of Organic Chemistry. 80(14). 7266–7274. 50 indexed citations
8.
Londregan, Allyn T., David W. Piotrowski, Kentaro Futatsugi, et al.. (2013). Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries. Bioorganic & Medicinal Chemistry Letters. 23(5). 1407–1411. 20 indexed citations
9.
Warmus, Joseph S., Cheryl L. Quinn, Clarke Taylor, et al.. (2012). Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC. Bioorganic & Medicinal Chemistry Letters. 22(7). 2536–2543. 28 indexed citations
10.
Galatsis, Paul, Bradley W. Caprathe, Dennis M. Downing, et al.. (2010). Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones. Bioorganic & Medicinal Chemistry Letters. 20(17). 5089–5094. 6 indexed citations
12.
Londregan, Allyn T., et al.. (2009). An improved amide coupling procedure for the synthesis of N-(pyridin-2-yl)amides. Tetrahedron Letters. 50(17). 1986–1988. 10 indexed citations
13.
Barrett, Stephen D., Alexander J. Bridges, David T. Dudley, et al.. (2008). The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorganic & Medicinal Chemistry Letters. 18(24). 6501–6504. 222 indexed citations
14.
Warmus, Joseph S., Cathlin Flamme, Stephen D. Barrett, et al.. (2008). 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase). Bioorganic & Medicinal Chemistry Letters. 18(23). 6171–6174. 60 indexed citations
15.
Kaufman, Michael D., Stephen D. Barrett, Cathlin Flamme, et al.. (2004). Synthesis and SAR development of PD 0325901, a potent and highly bioavailable MEK inhibitor.. Cancer Research. 64. 573–573. 1 indexed citations
16.
Warmus, Joseph S., et al.. (2000). Polyaromatic Scavenger Reagents (PAHSR):  A New Methodology for Rapid Purification in Solution-Phase Combinatorial Synthesis. Organic Letters. 2(13). 1807–1809. 18 indexed citations
17.
Warmus, Joseph S., Todd R. Ryder, John C. Hodges, Robert M. Kennedy, & Kenneth D. Brady. (1998). Rapid optimization of an ice inhibitor synthesis using multiple reaction conditions in a parallel array. Bioorganic & Medicinal Chemistry Letters. 8(17). 2309–2314. 22 indexed citations
18.
Lunney, Elizabeth A., Susan E. Hagen, John M. Domagala, et al.. (1994). A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related Analogs. Journal of Medicinal Chemistry. 37(17). 2664–2677. 70 indexed citations
19.
MEYERS, A. I., Joseph W. Guiles, Joseph S. Warmus, & Michael A. Gonzalez. (1991). Chiral lithio formamidines. Are they configurationally stable?. Tetrahedron Letters. 32(40). 5505–5508. 26 indexed citations
20.
Roush, William, A. P. ESSENFELD, & Joseph S. Warmus. (1987). Effect of dienophile activating group on the stereoselectivity of the intramolecular diels-alder reaction. Tetrahedron Letters. 28(22). 2447–2450. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026